author

 
Menu
Search
 
November 23, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

Meta

Julie Steenhuysen
Japan Times
WORLD / Science & Health / ANALYSIS
Jan 10, 2022
Pandemic fatigue makes the case for boosters a harder sell
Disease experts say that rapidly shifting public health messaging in the face of a quickly mutating virus has bred confusion and mistrust over the benefit of boosters.
Japan Times
WORLD / FOCUS
Dec 18, 2021
Omicron rewrites the COVID plan for 2022
As the omicron variant gains momentum in Europe and the United States, scientists are rewriting their expectations for the COVID-19 pandemic next year.
Japan Times
WORLD / ANALYSIS
Nov 30, 2021
How fast does it spread? Scientists ask whether omicron can outrun delta.
Questions remain over whether the COVID-19 variant will evade vaccine protection and whether it will cause more serious illness.
Japan Times
WORLD / ANALYSIS
Nov 9, 2021
COVID-19 pills no substitute for vaccines, disease experts say
Some experts fear the arrival of oral treatments for the coronavirus may further impede vaccination campaigns.
Japan Times
WORLD / Science & Health / ANALYSIS
Sep 3, 2021
Vaccine advisers to U.S. FDA face thorny question: Are COVID-19 boosters needed?
A fierce debate is expected around whether most Americans should get another shot rather than just those at high risk of severe illness.
Japan Times
WORLD
Aug 9, 2021
Beyond delta, scientists are watching new coronavirus variants
Scientists remain focused on delta, now the dominant variant rising rapidly around the world, but they are tracking others to see what may one day take its place.
Japan Times
WORLD / Science & Health
Jul 26, 2021
How the delta variant upends assumptions about the coronavirus
The delta variant is the fastest, fittest and most formidable version of the coronavirus that causes COVID-19 the world has encountered.
Japan Times
WORLD / Science & Health / FOCUS
Jul 21, 2021
Global quest underway to speed up COVID-19 vaccine trials
Researchers are trying to determine just what level of antibodies a vaccine must produce to provide protection against the illness.
Japan Times
WORLD / ANALYSIS
Jul 13, 2021
Pfizer bid for booster vaccines premature, experts say, with more data needed
The drugmaker's push for health regulators to authorize a third dose of its COVID-19 shot is not yet backed by evidence, despite the fast-spreading delta variant, vaccine experts said.
Japan Times
WORLD / Science & Health / ANALYSIS
Jun 11, 2021
U.S. FDA faces mounting criticism over Alzheimer's drug approval
The drug was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer's, rather than proof that it slows progression of the disease.
Japan Times
WORLD / ANALYSIS
Apr 1, 2021
In mutant variants, has the coronavirus already revealed its hand?
Emergence of the same few mutations simultaneously in different parts of the world gives scientists cautious optimism that there may be limits on the pandemic's endurance.
Japan Times
WORLD / FOCUS
Mar 4, 2021
'When will it end?': How a changing virus is reshaping scientists’ views on COVID-19
Vaccine breakthroughs had initially sparked hope that the virus could be largely contained, but data on new variants has undercut that optimism.
Japan Times
WORLD / FOCUS
Jan 31, 2021
Pandemic spurs quest to enroll more Black Americans in vaccine trials
The efforts rely on grassroots partners such as churches and health centers, and aim to topple long-standing barriers that keep minorities from participating in trials.
Japan Times
WORLD / FOCUS
Jan 29, 2021
Racing the virus: Why tweaking vaccines to fight variants won't be simple
After developing and rolling out COVID-19 vaccines at record speed, drugmakers are already facing variants of the rapidly-evolving coronavirus that may render them ineffective.
Japan Times
WORLD / Science & Health / FOCUS
Nov 18, 2020
How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine
Researchers were asked to tackle something that had never been done before: design a vaccine to stop a pandemic in its tracks in less than a year.
Japan Times
WORLD / Science & Health / FOCUS
Aug 31, 2020
Scientists see downsides to top COVID-19 vaccines from Russia and China
High-profile COVID-19 vaccines developed in Russia and China share a potential shortcoming: They are based on a common cold virus that many people have been exposed to, potentially limiting their effectiveness, some experts say.
Japan Times
BUSINESS / Companies / FOCUS
Feb 3, 2019
Bypassing U.S. regulators, Takeda takes its dengue shot to the tropics first
A new vaccine for the dengue virus is taking a potentially risky road to prevent the mosquito-borne disease that infects nearly 400 million people each year.
Japan Times
BUSINESS / Companies
Dec 1, 2016
Takeda drug could be part of functional cure for HIV: study
Dr. Anthony Fauci doesn't get too excited about the results of animal studies, and he doesn't make house calls.
Japan Times
WORLD / Science & Health
May 14, 2015
How DNA sequencing is transforming the hunt for new drugs
Drug manufacturers have begun amassing enormous troves of human DNA in hopes of significantly shortening the time it takes to identify new drug candidates, a move some say is transforming the development of medicines.
Japan Times
WORLD / Science & Health
Dec 22, 2014
Cure sought in the blood of Ebola survivors
For months, Vanderbilt University researcher Dr. James Crowe has been desperately seeking access to the blood of U.S. Ebola survivors, hoping to extract the proteins that helped them overcome the deadly virus for use in new, potent drugs.
Japan approves ¥21.9 trillion stimulus plan
The policy chiefs of the Democratic Party for the People, Liberal Democratic Party and Komeito — Makoto Hamaguchi (left), Itsunori Onodera (center) and Mitsunari Okamoto — shake hands after reaching an agreement on an economic stimulus package on Wednesday.
Tokyo Metro’s overseas efforts begin in earnest with London deal
Tokyo Metro will soon have a role in the running of London's Elizabeth Line, a major train route serving the U.K.’s capital city and environs.
Saitama court bans demonstrations over anti-Kurd hate speech
Kurdish people in Japan in 2015. A court injunction has banned acts that defame the Japan Kurdish Cultural Association and are disrespectful, such as putting up banner flags or handing out fliers with hate speech like “Refugees should go back to their home countries.”
China reinstates visa-free travel for Japanese nationals
Beijing Daxing International Airport
U.S. aircraft carrier returns to Japan carrying navy’s ‘most capable fighter’
U.S. 7th Fleet Commander Vice Adm. Fred Kacher speaks to reporters shortly after the arrival of aircraft carrier USS George Washington at Yokosuka naval base in Kanagawa Prefecture on Friday.
Shohei Ohtani wins National League MVP award
Shohei Ohtani celebrates after hitting a three-run home run against the Padres during the National League Division Series at Dodger Stadium in Los Angeles last month.
The slow-burn success of ‘A Samurai in Time’
A 19th-century warrior gets struck by lightning and wakes to find himself in 21st-century Kyoto in Junichi Yasuda’s surprise hit “A Samurai in Time.”
Around a quarter of Japan married couples in their 20s met through dating apps
A survey released by an organization promoting “Good Couples Day” shows that 24% of couples in their 20s met their marriage partner through a dating app.
'Tokyo Swindlers': Get deep into the minds of real estate con artists
In Ko Shinjo's "Tokyo Swindlers," a group of con artists manipulates real estate giants into falsified deals within the highly competitive, quick market.
Japan, U.K. and Italy discuss inviting more countries to joint fighter project
A new concept model of a next-generation fighter jet to be jointly developed by Japan, Britain and Italy is on display in Farnborough, Hampshire, in July.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?
By Kathryn Wortley

SUSTAINABLE JAPAN

Azabudai Hills, Tokyo’s green new downtown ‘village’
Azabudai Hills, Tokyo’s green new downtown ‘village’

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER